Experiences of using vedolizumab in the East Midlands, United Kingdom: A retrospective observational study

22/05/2018
23/04/2024
EU PAS number:
EUPAS23658
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Study results
Study results

Vedolizumab-5049 - Synopsis - _FINAL_V1 1_31JUL2019

English (711.73 KB - PDF) View document

Vedolizumab-5049_Synopsis_Redacted

English (794.32 KB - PDF) View document
Study report
Other information